Physician profile
Jarrad Teller
NPI 1578505418
$2,748.51
in general payments reported to CMS, 2019-2025
15 companies · $301 in 2025
The $301 reported for 2025 was more than what 92% of Chiropractor providers received nationally (typical 2025 total: $40.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $507 · 2021: $542 · 2022: $423 · 2023: $151 · 2024: $478 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,007.78 | 2019-2025 | Relistor, Trulance |
| Scilex Pharmaceuticals INC. | $205.41 | 2022-2025 | Ztlido |
| Valinor Pharma, LLC | $114.44 | 2023-2025 | Movantik |
| Redhill Biopharma INC. | $72.51 | 2020-2022 | |
| Forte Bio-Pharma LLC | $55.13 | 2020-2022 | |
| Depuy Synthes Sales INC. | $47.52 | 2023 | Orthovisc |
| Averitas Pharma INC. | $38.52 | 2024 | Qutenza |
| Arbor Pharmaceuticals, INC. | $35.95 | 2021 | |
| Biodelivery Sciences International, INC. | $33.33 | 2019 | |
| Zimmer Biomet Holdings, INC. | $26.43 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Zyla Life Sciences, INC. | $23.46 | 2019 | |
| Acerus Pharmaceuticals Corporation | $22.98 | 2022 | |
| Avanos Medical | $22.96 | 2022 | |
| Si-Bone, INC. | $22.44 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $19.65 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarrad Teller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.